, ,
Presentations this author is a contributor to:
The clinically active PARP inhibitor Olaparib ameliorates Doxorubicin-induced Cardiotoxicity in both in vitro and In vivo model (#282)
1:00 PM
Dongqing Kelly Chen
Lunch & Poster Viewing (Even Numbers)
Carfilzomib-induced cardiotoxicity: mechanisms & potential treatments. (#286)
1:00 PM
Tatt Jhong Haw
Lunch & Poster Viewing (Even Numbers)